{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:51:45Z","timestamp":1781934705562,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Pediatric Heart Network"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Fontan-associated liver disease (FALD) is a fibrotic liver disease in individuals with Fontan physiology. This study sought to determine the efficacy of treatment with udenafil, a phosphodiesterase type 5 inhibitor, for reducing liver congestion leading to a decreased liver stiffness and reduction in serologic biomarkers of liver fibrosis. In patients enrolling in the FUEL trial open label extension, liver stiffness measurements were obtained by ultrasound shear wave elastography (SWE) and magnetic resonance elastography (MRE); serum markers of liver fibrosis were measured by the Enhanced Liver Fibrosis (ELF) score. Change in liver stiffness and ELF score after 12 months of udenafil treatment were analyzed. In 88 subjects, 36 were previously treated with udenafil and 52 were udenafil-na\u00efve. The cohort\u2019s baseline liver stiffness was elevated by SWE, mean 2.0\u2009\u00b1\u20090.4\u00a0m\/sec (adult upper limit normal 1.5\u00a0m\/sec), and MRE, mean 5.3\u2009\u00b1\u20091.2\u00a0kPa (adult upper limit normal 2.8\u00a0kPa). After 12 months of udenafil treatment, there was no change in SWE (post-treatment mean 1.9\u2009\u00b1\u20090.3\u00a0m\/sec,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.28) nor change in MRE (post-treatment mean 5.2\u2009\u00b1\u20090.97\u00a0kPa,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.68). The cohort\u2019s baseline ELF score was elevated at 10.4\u2009\u00b1\u20091.0 according to values correlating with liver fibrosis in other diseases. ELF score decreased at 12 months to 9.8\u2009\u00b1\u20090.8 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Liver stiffness did not change following 12 months of udenafil treatment, but ELF scores significantly decreased. Further study is needed to understand the relationship of ELF score to age, but these results suggest the possibility that udenafil may alter the overall Fontan fibrotic milieu.\n                  <\/jats:p>","DOI":"10.1007\/s00246-026-04334-9","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:23:34Z","timestamp":1781933014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The FUEL FALD Study: Effects of Udenafil on Liver Stiffness and Fibrosis after Fontan"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8659-736X","authenticated-orcid":false,"given":"Kurt R.","family":"Schumacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Dillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Cartoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"DiMaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Frischhertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salil","family":"Ginde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan H.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagraj","family":"Kasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad Y.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"McCrindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Opotowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Paridon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Penny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Yetman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Zak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"issue":"7","key":"4334_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00246-012-0315-7","volume":"33","author":"J Rychik","year":"2012","unstructured":"Rychik J et al (2012) The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol 33(7):1001\u20131012","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"4334_CR2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.athoracsur.2009.05.076","volume":"88","author":"JS Tweddell","year":"2009","unstructured":"Tweddell JS et al (2009) Fontan palliation in the modern era: factors impacting mortality and morbidity. Ann Thorac Surg 88(4):1291\u20131299","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"4334_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.healun.2015.10.015","volume":"35","author":"SC Greenway","year":"2016","unstructured":"Greenway SC et al (2016) Fontan-associated liver disease: Implications for heart transplantation. J Heart Lung Transpl 35(1):26\u201333","journal-title":"J Heart Lung Transpl"},{"issue":"6","key":"4334_CR4","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jtcvs.2004.10.005","volume":"129","author":"AA Ghaferi","year":"2005","unstructured":"Ghaferi AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129(6):1348\u20131352","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"4334_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/jcp.2007.052365","volume":"61","author":"TJ Kendall","year":"2008","unstructured":"Kendall TJ et al (2008) Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol 61(4):504\u2013508","journal-title":"J Clin Pathol"},{"issue":"5","key":"4334_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/hrt.2006.094516","volume":"93","author":"CH Kiesewetter","year":"2007","unstructured":"Kiesewetter CH et al (2007) Hepatic changes in the failing Fontan circulation. Heart 93(5):579\u2013584","journal-title":"Heart"},{"issue":"1","key":"4334_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00246-012-0402-9","volume":"34","author":"MC Schwartz","year":"2013","unstructured":"Schwartz MC et al (2013) Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery. Pediatr Cardiol 34(1):135\u2013142","journal-title":"Pediatr Cardiol"},{"issue":"22","key":"4334_CR8","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.jacc.2023.03.421","volume":"81","author":"MJ Lewis","year":"2023","unstructured":"Lewis MJ et al (2023) Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation. J Am Coll Cardiol 81(22):2149\u20132160","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"4334_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1161\/CIRCULATIONAHA.119.044352","volume":"141","author":"DJ Goldberg","year":"2020","unstructured":"Goldberg DJ et al (2020) Results of the FUEL Trial. Circulation 141(8):641\u2013651","journal-title":"Circulation"},{"key":"4334_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbrc.2021.04.038","volume":"558","author":"HM Yu","year":"2021","unstructured":"Yu HM, Chung HK, Park KS (2021) The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function. Biochem Biophys Res Commun 558:57\u201363","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"4334_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.12968\/hmed.2018.79.12.694","volume":"79","author":"JW Day","year":"2018","unstructured":"Day JW, Rosenberg WM (2018) The enhanced liver fibrosis (ELF) test in diagnosis and management of liver fibrosis. Br J Hosp Med (Lond) 79(12):694\u2013699","journal-title":"Br J Hosp Med (Lond)"},{"issue":"2","key":"4334_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jhep.2013.03.016","volume":"59","author":"R Lichtinghagen","year":"2013","unstructured":"Lichtinghagen R et al (2013) The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol 59(2):236\u2013242","journal-title":"J Hepatol"},{"issue":"9","key":"4334_CR13","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/liv.12525","volume":"34","author":"JH Wang","year":"2014","unstructured":"Wang JH et al (2014) Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis. Liver Int 34(9):1340\u20131348","journal-title":"Liver Int"},{"issue":"3","key":"4334_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00330-013-3046-0","volume":"24","author":"AE Bohte","year":"2014","unstructured":"Bohte AE et al (2014) Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C. Eur Radiol 24(3):638\u2013648","journal-title":"Eur Radiol"},{"issue":"3","key":"4334_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00247-012-2531-y","volume":"43","author":"DB Wallihan","year":"2013","unstructured":"Wallihan DB, Podberesky DJ (2013) Hepatic pathology after Fontan palliation: spectrum of imaging findings. Pediatr Radiol 43(3):330\u2013338","journal-title":"Pediatr Radiol"},{"issue":"3","key":"4334_CR16","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jtcvs.2015.09.079","volume":"151","author":"SS Kutty","year":"2016","unstructured":"Kutty SS et al (2016) Hepatic stiffness in the bidirectional cavopulmonary circulation: The Liver Adult-Pediatric-Congenital-Heart-Disease Dysfunction Study group. J Thorac Cardiovasc Surg 151(3):678\u2013684","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"4334_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/2150135114530172","volume":"5","author":"JL Melero-Ferrer","year":"2014","unstructured":"Melero-Ferrer JL et al (2014) Fontan Circulation in Adult Patients: Acoustic Radiation Force Impulse Elastography as a Useful Tool for Liver Assessment. World J Pediatr Congenit Heart Surg 5(3):365\u2013371","journal-title":"World J Pediatr Congenit Heart Surg"},{"issue":"6","key":"4334_CR18","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1007\/s00330-016-4614-x","volume":"27","author":"FW DiPaola","year":"2017","unstructured":"DiPaola FW et al (2017) Effect of Fontan operation on liver stiffness in children with single ventricle physiology. Eur Radiol 27(6):2434\u20132442","journal-title":"Eur Radiol"},{"issue":"6","key":"4334_CR19","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/jmri.24496","volume":"40","author":"DB Wallihan","year":"2014","unstructured":"Wallihan DB et al (2014) Relationship of MR elastography determined liver stiffness with cardiac function after Fontan palliation. J Magn Reson Imaging 40(6):1328\u20131335","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"4334_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1148\/radiol.2017160622","volume":"284","author":"M Yin","year":"2017","unstructured":"Yin M et al (2017) Distinguishing between Hepatic Inflammation and Fibrosis with MR Elastography. Radiology 284(3):694\u2013705","journal-title":"Radiology"},{"issue":"9","key":"4334_CR21","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.amjcard.2019.07.052","volume":"124","author":"T Alsaied","year":"2019","unstructured":"Alsaied T et al (2019) Relation of Magnetic Resonance Elastography to Fontan Failure and Portal Hypertension. Am J Cardiol 124(9):1454\u20131459","journal-title":"Am J Cardiol"},{"issue":"2","key":"4334_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1148\/radiol.2020192437","volume":"296","author":"RG Barr","year":"2020","unstructured":"Barr RG et al (2020) Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement. Radiology 296(2):263\u2013274","journal-title":"Radiology"},{"issue":"1","key":"4334_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1053\/j.gastro.2008.09.013","volume":"136","author":"V Nobili","year":"2009","unstructured":"Nobili V et al (2009) Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 136(1):160\u2013167","journal-title":"Gastroenterology"},{"issue":"3","key":"4334_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1148\/radiol.2020201513","volume":"297","author":"AT Trout","year":"2020","unstructured":"Trout AT et al (2020) Normal Liver Stiffness Measured with MR Elastography in Children. Radiology 297(3):663\u2013669","journal-title":"Radiology"},{"key":"4334_CR25","doi-asserted-by":"crossref","unstructured":"Goldberg DJ et al (2017) Hepatic Fibrosis Is Universal Following Fontan Operation, and Severity is Associated With Time From Surgery: A Liver Biopsy and Hemodynamic Study. J Am Heart Assoc, 6(5)","DOI":"10.1161\/JAHA.116.004809"},{"issue":"3","key":"4334_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s00247-018-4311-9","volume":"49","author":"A Srinivasan","year":"2019","unstructured":"Srinivasan A et al (2019) Percutaneous liver biopsy in Fontan patients. Pediatr Radiol 49(3):342\u2013350","journal-title":"Pediatr Radiol"},{"issue":"3","key":"4334_CR27","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1148\/radiol.2018172099","volume":"287","author":"AT Trout","year":"2018","unstructured":"Trout AT et al (2018) Diagnostic Performance of MR Elastography for Liver Fibrosis in Children and Young Adults with a Spectrum of Liver Diseases. Radiology 287(3):824\u2013832","journal-title":"Radiology"},{"issue":"1","key":"4334_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1148\/radiol.2015142141","volume":"278","author":"M Yin","year":"2016","unstructured":"Yin M et al (2016) Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations. Radiology 278(1):114\u2013124","journal-title":"Radiology"},{"issue":"3","key":"4334_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MCG.0000000000000128","volume":"49","author":"FF Fernandes","year":"2015","unstructured":"Fernandes FF et al (2015) Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients. J Clin Gastroenterol 49(3):235\u2013241","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"4334_CR30","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/liv.14908","volume":"41","author":"LG Draijer","year":"2021","unstructured":"Draijer LG et al (2021) Diagnostic accuracy of fibrosis tests in children with non-alcoholic fatty liver disease: A systematic review. Liver Int 41(9):2087\u20132100","journal-title":"Liver Int"},{"issue":"1","key":"4334_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13019-020-01335-4","volume":"15","author":"R Kowatari","year":"2020","unstructured":"Kowatari R et al (2020) Long-term results of additional pulmonary blood flow with bidirectional cavopulmonary shunt. J Cardiothorac Surg 15(1):279","journal-title":"J Cardiothorac Surg"},{"key":"4334_CR32","doi-asserted-by":"crossref","unstructured":"Alsaied T et al (2020) Myocardial fibrosis, diastolic dysfunction and elevated liver stiffness in the Fontan circulation. Open Heart, 7(2)","DOI":"10.1136\/openhrt-2020-001434"},{"issue":"8","key":"4334_CR33","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1017\/S1047951121000159","volume":"31","author":"M Possner","year":"2021","unstructured":"Possner M et al (2021) Dynamic exercise changes in venous pressure and liver stiffness in Fontan patients: effects of Treprostinil. Cardiol Young 31(8):1283\u20131289","journal-title":"Cardiol Young"},{"issue":"6","key":"4334_CR34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/petr.12116","volume":"17","author":"I Goldschmidt","year":"2013","unstructured":"Goldschmidt I et al (2013) The use of transient elastography and non-invasive serum markers of fibrosis in pediatric liver transplant recipients. Pediatr Transpl 17(6):525\u2013534","journal-title":"Pediatr Transpl"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04334-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-026-04334-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04334-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:23:36Z","timestamp":1781933016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-026-04334-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":34,"alternative-id":["4334"],"URL":"https:\/\/doi.org\/10.1007\/s00246-026-04334-9","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"David Goldberg and Bryan Goldstein are now consultants for Mezzion Pharmaceuticals. Mezzion produces udenafil and funded the Pediatric Heart Network to complete this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}